1. Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections

   • Matthew W. McCarthy

   Review Article Open access 17 February 2022 Pages: 113 - 117

2. Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

   • Liangying Gan
   • Panpan Xie
   • Li Zuo

   Original Research Article Open access 05 April 2022 Pages: 119 - 129

   

3. First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants

   • Fumihiko Koiwa
   • Rie Yazawa
   • Tadao Akizawa

   Original Research Article Open access 25 March 2022 Pages: 131 - 140

   

4. A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects

   • Ashit Trivedi
   • Omar Mather
   • Edward Lee

   Original Research Article Open access 13 March 2022 Pages: 141 - 146

   

5. Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study

   • Ashit Trivedi
   • Y.-H. Kiang
   • Edward Lee

   Original Research Article Open access 12 April 2022 Pages: 147 - 154

   

6. Hydroxychloroquine Blood Concentrations Can Be Clinically Relevant Also After Drug Discontinuation

   • Simona De Gregori
   • Francesco Falaschi
   • Antonio Di Sabatino

   Original Research Article Open access 13 May 2022 Pages: 155 - 163

   

7. Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9

   • Theodore J. Kottom
   • Kyle Schaefbauer
   • Andrew H. Limper

   Original Research Article Open access 29 April 2022 Pages: 165 - 173

   

8. Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers

   • Yan-ping Liu
   • Ming-hui Hu
   • Yu Cao

   Original Research Article Open access 30 May 2022 Pages: 175 - 182